KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for TherapeuticsMD (TXMD) over the last 8 years, with Sep 2025 value amounting to 0.07.

  • TherapeuticsMD's Asset Utilization Ratio rose 80.87% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 80.87%. This contributed to the annual value of 0.04 for FY2024, which is 120.29% up from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Asset Utilization Ratio is 0.07, which was up 8.65% from 0.07 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Asset Utilization Ratio ranged from a high of 1.33 in Q3 2023 and a low of 0.03 during Q2 2024.
  • In the last 3 years, TherapeuticsMD's Asset Utilization Ratio had a median value of 0.05 in 2025 and averaged 0.35.
  • In the last 5 years, TherapeuticsMD's Asset Utilization Ratio surged by 830.44% in 2023 and then slumped by 97.82% in 2024.
  • TherapeuticsMD's Asset Utilization Ratio (Quarterly) stood at 0.46 in 2021, then spiked by 35.95% to 0.62 in 2022, then slumped by 95.19% to 0.03 in 2023, then soared by 49.69% to 0.04 in 2024, then spiked by 80.87% to 0.07 in 2025.
  • Its Asset Utilization Ratio was 0.07 in Q3 2025, compared to 0.07 in Q2 2025 and 0.05 in Q1 2025.